Last updated: 11/07/2018 17:54:55
An Extended, Stratified Follow-on Study In Paediatric Subjects With Chronic Hepatitis B Who Have Completed Previous Lamivudine Studies
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: An Extended, Stratified Follow-on Study In Paediatric Subjects With Chronic Hepatitis B Who Have Completed Previous Lamivudine Studies
Trial description: An Extended, Stratified Follow-on Study In Paediatric Subjects With Chronic Hepatitis B Who Have Completed Previous Lamivudine Studies
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
AN EXTENDED, STRATIFIED, FOLLOW-ON STUDY IN CHILDREN WITH CHRONIC HEPATITIS B (CHB) WHO HAVE COMPLETED PREVIOUS LAMIVUDINE STUDIES.. Etienne M. Sokal, Jacek Mizerski Poland Marek Woynarowski Wojciech Sluzewski Isabel B. Badia Deirdre A. Kelly Kathleen B. Schwarz Jorge A. Areias Nancy Little Stephen Gardner Mary Castiglia Maureen M. Jonas, 54th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA; USA, 10/24/2003
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2003-15-01
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website